Summary
This 2025 narrative review, published in the Journal of Biomedical Science, provides an overview of recent advances in chitosan-based formulations for therapeutic use. Chitosan, a biopolymer derived from chitin, is examined in the context of its pharmacological versatility, including roles in targeted drug delivery, wound management, and antimicrobial applications. The review synthesises emerging evidence on formulation strategies and likely addresses bioavailability, safety profiles, and clinical potential, though specific findings should be verified against the full text.
UK applicability
Chitosan-based therapeutics are an active area of pharmaceutical and biomedical research globally, including within UK academic and clinical settings; findings from this international review would be broadly applicable to UK researchers and clinicians exploring biopolymer-based drug delivery or wound care innovations.
Key measures
Therapeutic efficacy indicators; drug delivery performance; antimicrobial and anti-inflammatory properties; biocompatibility and biodegradability assessments
Outcomes reported
The review surveys the therapeutic applications of chitosan-based formulations, likely covering drug delivery, wound healing, antimicrobial activity, and other biomedical uses reported across recent literature.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.